Rama Krishna Narla

Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent Efficacy.

G. Fenalti, L. LeBrun, Dan Zhu, 2019, Journal of medicinal chemistry.

The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-alpha production with antitumor activity.

Lei Wu, P. Schafer, L. Corral, 2006, Cancer research.